We have examined the RNAs involved in the heterologous protection of adult mice from otherwise lethal intranasal infection with mouse-adapted human A/WSN (H1N1) by defective interfering (DI) equine A/equine/Newmarket/7339/79 (H3N8: EQV) influenza virus, as well as the RNAs involved in the protection of WSN-or EQV-infected mice by their homologous DI viruses. The aim of this study was to describe the types of defective RNAs present in protected mice in order to guide the design of potentially protective DI RNAs. The interfering and mouse-protecting activity of DI virus was destroyed by prolonged UV irradiation (iDI virus) demonstrating that protection correlated with an active DI genome, and not viral antigen. Protected mice were all infected but suffered a lower degree of morbidity than those given iDI virus. The DI EQV inoculum contained defective segment 1±8 RNAs while DI WSN inoculum contained only defective segment 1±6 RNAs. However lungs of mice given EQV ϩ DI EQV contained only defective segments 1±4 or 1±6 RNAs (mouse-to-mouse variation), while control mice given EQV or EQV ϩ iDI EQV contained few very defective RNAs. Thus prevention of death was the result of quantitative and/or qualitative differences in defective RNAs administered to the mice. Only defective segments 1±3 RNAs were isolated from the lungs of mice given WSN ϩ DI WSN, confirming the earlier report of Noble and Dimmock (1995) . A detailed analysis showed that most defective RNAs isolated from the lungs of mice protected from a lethal WSN infection by DI EQV were EQV in origin. Thus, as no infectious EQV was present, these defective RNAs from the DI EQV inoculum must have been heterologously replicated in mouse lung by WSN. All defective segment 3±6 RNAs isolated were of EQV origin, indicating that they were replicated by WSN in preference to its own. Defective segments 1 and 2 were a mixture of EQV and WSN RNAs. Of 17 defective EQV segment 1±3 sequences from mouse lung, all but three differed in their primary central deletion from 20 defective RNAs isolated from the inoculum. No bias in the break points was evident. A number of minor deletions of 2 or more nts were also present in defective EQV and WSN RNAs in segments 1 and 2, but none in segment 3. Their 5Ј, but not 3Ј, breakpoints were heterogeneous, suggesting that defective RNAs were generated during positive strand synthesis. Two cloned EQV-defective segment 3 RNAs were chimeras containing a 30 nt insert from segment 1. Most defective RNAs possessed at least 178 nts from the 5Ј end of vRNA. The amount of 5Ј sequence present in those RNAs correlated with the segment of origin, suggesting that this was the minimum required for propagation of viral RNA in mouse lung and hence possibly for protection also.
INTRODUCTION
Influenza A virus has a single stranded negative sense RNA genome consisting of eight separate segments. In addition virus particles may contain small defective RNAs that have arisen during multiplication by internal deletion of genomic segments (Davis et al., 1980) . These are amplified relative to genomic segments and can be packaged efficiently in place of the genome segments from which they were derived (Duhaut and McCauley, 1996) . At least some of these deleted genomes are defective interfering (DI) RNAs (Huang and Baltimore, 1970) that have the ability to interfere with the multiplication of the influenza virus in vitro (von Magnus, 1954; Nayak, 1980; Nayak et al., 1985 Nayak et al., , 1989 and can protect mice from influenza A virus infections in vivo (Dimmock, 1996) . Recent work has demonstrated that A/equine/Newmarket/ 7339/79 (H3N8: EQV) DI virus protected 100% mice against an otherwise lethal intranasal EQV pneumonia and a sublethal infection that more closely resembles human influenza and acted by inhibiting virus multiplication in the lungs of infected adult mice (Noble and Dimmock, 1994) . In addition DI EQV protected mice against the heterologous WSN subtype, suggesting that DI viruses might eventually be useful in a prophylactic treatment that can circumvent both antigenic drift and antigenic shift. In addition WSN-infected mice could be protected by co-inoculation with DI WSN, although protection in this instance was due to the prevention of virus-induced suppression of the control of T cell numbers in the lung that would otherwise result in a fatal lung consolidation . DI WSN-mediated protection was demonstrated in three 1 To whom reprint requests should be addressed. different strains of mice (Morgan et al., 1993) with survival of approximately 80% of otherwise lethally infected animals (Dimmock et al., 1986; McLain et al., 1992; Morgan and Dimmock, 1992; Morgan et al, 1993) .
Studies of defective RNAs that are associated with the protection of mice from a lethal homologous infection with WSN showed that certain of the inoculated defective RNAs were preferentially replicated in the infected mouse (Noble and Dimmock, 1995) . However, this study was based mainly on RNA size analysis and was limited because RT-PCR did not detect all genomic segments equally well and only a small number of defective RNAs were sequenced. The major study to date on sequences of defective RNAs generated in chick embryos involved A/PR/8/34 (H1N1: Jennings et al., 1983) , but the stability of these RNAs on passage and their interfering ability was not determined.
Here we report on a study of mice infected intranasally with a lethal dose of WSN (H1N1) or EQV (H3N8) influenza virus that were protected against death by intranasal inoculation with homologous or heterologous DI virus (WSN ϩ DI WSN, EQV ϩ DI EQV, or WSN ϩ DI EQV). We compared the defective RNAs present in the inoculum with those isolated from mice protected from lethal disease using RT-PCR and segment-specific primers. The preferential replication of WSN-defective RNAs 1, 2, and 3 in mice inoculated with WSN ϩ DI WSN (Noble and Dimmock, 1995) was confirmed, but there was less selection of defective RNAs of EQV origin in mice inoculated with EQV ϩ DI EQV or WSN ϩ DI EQV. Although there were only one or two RT-PCR bands per RNA segment (200±600 bp), each contained the sequences of many different defective RNAs. Those sequences involved in the heterologous protection of mice by DI EQV from a lethal WSN infection have been studied in detail for the first time. Because there was no infectious EQV present in the system, defective EQV RNAs could not be generated de novo, and all defective EQV RNAs isolated from lung must have been replicated by the heterologous WSN. This enabled us to distinguish the potentially protective defective EQV RNAs of the inoculum from the nonprotective WSN-defective RNAs that are unavoidably present in the infectious challenge virus. The majority of defective RNAs isolated from mice inoculated with WSN ϩ DI EQV were of EQV origin, and most of these 47 RNA sequences were unique, with only three occurring in both mouse lungs and the inoculum. Virtually all RNAs analysed possessed at least 178 nucleotides of the 5Ј end of vRNA. EQV-defective RNAs isolated from protected mice were on average longer than those present in the inoculum, suggesting that internal sequences may play a role in protection. It is concluded that virus strain, segment of origin, and quantity of defective RNA are also likely to be relevant to the powerful protection that these RNAs are able to exert against lethal influenza.
RESULTS

DI influenza virus protects mice from a normally lethal dose of WSN or EQV
The morbidity and mortality associated with a lethal intranasal dose of WSN (H1N1) and EQV (H3N8) are shown in Figs. 1A and 1C (WSN) and Fig. 1B (EQV) . Mice given WSN developed the first clinical sign at Day 3 or 4 after infection, whereas those given EQV remained healthy until Day 6. All infected mice lost weight compared with noninfected or mock-infected controls (data not shown). All mice were protected from the lethal effect of WSN by intranasal inoculation with either homologous DI WSN (Fig. 1A) or heterologous DI EQV (Fig. 1C) and from EQV by inoculation with DI EQV (Fig. 1B) . Mice given DI virus showed either no clinical disease (DI EQV) or only mild transient clinical signs (DI WSN) in three separate experiments. Inactivated DI virus (iDI), which had been given prolonged UV-irradiation to destroy interfering activity, afforded little protection, indicating that the majority of the observed protection was mediated by an active DI genome rather than by stimulation of host defence responses with virus antigen. These results are in complete agreement with previous studies by Dimmock (1994, 1995) .
RT-PCR analysis of defective RNAs present in mouseprotecting DI EQV and DI WSN inoculum preparations DI virus inocula given to the mice in the previous section were analyzed by RT-PCR using primer pairs specific for the ends of each of the eight genomic segments as described in Materials and Methods (see also Table 1 ). Genomic segments 4±8 (890±1778 nts) were visible in DI EQV ( Fig.   FIG. 2 . RT-PCR products obtained from RNA extracted from the DI EQV (DI) and iDI EQV (iDI) (A) and the DI WSN (DI) and iDI WSN (iDI) (B) inocula used in Fig. 1 . RNA from the lungs of mice infected with EQV alone (Virus) is shown for comparison. RNA was extracted and amplified by RT-PCR using terminal 5Ј and 3Ј primers. In (A), the primers used were complementary to the first 25 nts of EQV 5Ј and 3Ј termini for all segments, except for the 5Ј termini of segments 3 and 8 for which UNI2B was used. In (B), the primers used were complementary to the first 25 nucleotides of the 3Ј ends of EQV segments 1, 2, 3, 5, 7, and 8, and to the first 20 nts of the 3Ј ends of WSN segment 4 and 6. 5Ј primers were complementary to the first 25 nts of EQV segments 1, 2, 5, and 7. The UNI2B primer homologous to all eight segments of both viruses was used for segments 3, 4, 6, and 8. EQV segment 4 primers were used for the virus control only. The RNA segment number is indicated at the top of each lane. Genomic length RNAs range from 0.89 to 2.4 kb (see Virus), and in the DI panels are distinguished from defective RNAs by a vertical arrow (2). The smaller bands in segment 3 of DI EQV (A) and segment 7 of DI WSN (B) are the same size as primer dimers. M, marker. b UNI2B (Noble and Dimmock, 1995) .
2A) and 5±8 in DI WSN inocula (Fig. 2B) , although genomic segment 6 was reduced in the latter. The absence of the larger full-length genomic segments is almost certainly due to the short pulse of UV irradiation that was used to destroy infectivity contained in these preparations, and no genomic segments were visible in the iDI inocula that had been given prolonged UV-irradiation ( Fig. 2A) . Defective RNAs derived from segments 1±8 were amplified from the DI EQV although those from defective EQV segments 7 and 8 gave faint bands ( Fig. 2A) , whereas defective RNAs from DI WSN were amplified from segments 1±6 (Fig. 2B) . Defective DNA bands ranged in size from approximately 250 to 600 bp. The difference between DI EQV and iDI EQV was qualitative and, after prolonged UV-irradiation, defective bands from segments 1 and 2 only remained in the iDI virus ( Fig. 2A) . The destruction of EQV-defective RNAs was consistent with the concomitant loss of mouse-protecting activity observed in Fig. 1 , while the isolation of segment 1 and 2 defective bands from iDI EQV suggests that they were present in the original preparation in relatively greater concentrations than those derived from the other segments. RT-PCR bands from defective segments 1±6 of all UV-inactivated iDI WSN preparations were reproducibly of lower intensity (Fig. 2B , data not shown), but as this is not a quantitative procedure, we do not know the extent of the reduction in defective RNAs. RT-PCR of the lungs of mice infected with EQV yielded EQV genomic segments but no defective EQV RNAs, indicating that the latter, when isolated from mice given DI EQV, were not artefactual ( Figs. 2A and 2B ).
Comparative analysis of defective RNAs isolated from the lungs of mice protected from lethal influenza by inoculation with DI WSN or DI EQV Mice were protected from a lethal WSN or EQV influenza infection by intranasal inoculation of DI virus as described above (Fig. 1) . When virus infectivity reached a peak in the lungs (Day 2 p.i. for EQV and Day 5 p.i. for WSN; data not shown), lungs were removed and RNA extracted. This was adjusted to 1 g/l and RT-PCR carried out. Five or six sets of data were analysed for each of the experiments reported below. No cDNA bands were amplified from RNA extracted from mock-infected mouse lungs in any experiment (e.g., Figs. 3A-3C ).
Mice inoculated with WSN, WSN ϩ DI WSN, or WSN ϩ iDI WSN (Fig. 3A) . DNA bands corresponding to genomic segments 1±8 of infectious WSN were amplified from all groups of infected mice. Defective RNAs derived from WSN segments 1, 2, and 3 (200±600 nts) were reproducibly detected in lungs of mice inoculated with WSN ϩ DI WSN, WSN ϩ iDI WSN, or WSN alone. However only mice inoculated with WSN ϩ DI WSN survived the infection, suggesting that the DI RNAs present in DI WSN were mouse-protecting because they were either qualitatively or quantitatively different from those present in the infectious virus preparation. Faint bands, amplified from defective RNAs derived from WSN segments 4±6, were sometimes present in mice inoculated with WSN ϩ iDI WSN but not from the other groups.
Mice inoculated with EQV, EQV ϩ DI EQV, or EQV ϩ iDI EQV (Fig. 3B ). DNA bands corresponding to all eight genomic segments of infectious EQV were amplified from all groups of infected mice. However those from mice given EQV ϩ DI EQV were more difficult to detect than in mice given EQV or EQV ϩ iDI EQV. Although the RT-PCR technique is not quantitative, this result is consistent with the observed inhibition of virus multiplication in the lungs of infected mice given DI EQV (Noble and Dimmock, 1994 ; data not shown). Lungs of mice inoculated with EQV ϩ DI EQV contained defective EQV RNAs of 200±550 nts derived from either segments 1±4 (as in Fig. 3B ) or 1±6 (data not shown), depending on the mouse analysed. However, the lungs of mice inoculated with EQV or EQV ϩ iDI EQV contained very few detectable defective EQV RNAs. Protection from death correlated directly, therefore, with the presence of EQV-defective RNAs in the lung.
Mice inoculated with WSN, WSN ϩ DI EQV, or WSN ϩ iDI EQV (Fig. 3C ). The EQV primers amplify not only EQV-defective RNAs from all segments but also WSN full-length and defective RNAs corresponding to segments 1±3, 5, 7, and 8. RNAs from WSN segments 4 and 6 are not amplified by these primers. Lungs of mice inoculated with WSN by definition contain only WSNdefective RNAs. Lungs of mice inoculated with either WSN ϩ DI EQV or WSN ϩ iDI EQV contained defective RNAs (200±600 nts) derived from segments 1±4 or from segments 1±6 (as in Fig. 3C ), depending on the mouse analysed. The provenance and properties of these defective RNAs were determined by further analysis (see below). No reduction in intensity of RT-PCR bands in mice given WSN ϩ DI EQV is seen in Fig. 3C although multiplication of WSN is inhibited under these conditions (Noble and Dimmock, 1994) .
Identification of the virus of origin of defective RNAs isolated from the lungs of mice protected from a lethal WSN infection by inoculation with DI EQV
DNAs from RT-PCR bands corresponding to defective RNAs isolated from the lungs of the protected mice inoculated with WSN ϩ DI EQV (as shown in Fig. 1C ) were cloned into pBluescript. All clones obtained were cut with PstI and HindIII, which excised defective DNAs intact from the plasmid vector. Defective virus sequences were then analysed using enzymes that restricted defective WSN DNA but not defective EQV DNA. For example, NruI and EcoRI cut small fragments from the ends of excised segment 1 defective WSN DNAs and reduced them in size, while segment 1 defective EQV DNAs were unaltered (Fig. 4) . The identification of some RNAs was confirmed by sequencing. Table 2 summarises the results of an analysis of defective RNAs derived from segments 1, 2, and 3. The majority of defective segments 1, 2, and 3 isolated from the lungs of mice, protected by inoculation with WSN ϩ EQV DI, were of EQV origin in the proportions 53, 74, and 100%, respectively. In contrast, lungs of mice that had been inoculated with WSN ϩ iDI EQV yielded a lower proportion of defective EQV segments 1, 2, 3, and 4 (0, 35, 55, and 100%, respectively), suggesting that fewer protective defective EQV RNAs were present. Defective segment 4 DNAs were isolated from lungs of mice given WSN ϩ iDI EQV (Table 2) Fig. 1 . Representative mice were sacrificed at the peak of lung virus titer (2 days p.i. for EQV, 5 days p.i. for WSN) and RNA extracted from their lungs. After normalisation, RNA was amplified by RT-PCR using terminal 5Ј and 3Ј primers. In (A), we used WSN primers as described for Fig. 2B , and in (B) and (C), we used EQV primers as described for Fig. 2A . RNA segment numbers are indicated at the top of each lane. Genomic length RNAs are visible (segment 8, 0.89 kb to segments 1 and 2, 2.4 kb) in all lanes except segments 4 and 6 in (C) because EQV primers do not detect these WSN RNAs. M, marker. though none could be detected in the iDI inoculum ( Fig.  2A) . Their identity was confirmed by sequence analysis.
Analysis of the sequence of defective RNAs isolated from DI EQV inoculum and from lungs of mice protected from a lethal WSN infection by inoculation with DI EQV EQV and WSN segment 1±3 defective RNAs, isolated and RT-PCR amplified from the inoculum and from infected mouse lungs as described above, were cloned and sequenced. The analysis of 51 sequences (47 EQV and 4 WSN) is shown in Table 3 . Most sequences were unique even though there were only one or two major bands of DNA per segment on gel electrophoresis (e.g., Fig. 3C ). The four WSN RNAs were isolated from mouse lung: three originated from segment 1 and one from segment 2. Only three defective EQV RNA sequences were isolated from both the inoculum and the protected mice, one from each of segments 1, 2, and 3 (Table 3 ).
All defective RNAs contained the expected central deletion. All segment 3 defective RNAs examined had only the central deletion. Of the others, 33% of EQV segment 1 and 47% of EQV segment 2 defective RNAs had a smaller second deletion of two or more nucleotides. This type of defective RNA was evenly distributed between the inoculum and the mouse lung-derived RNAs, suggesting that it had arisen during generation and passage in the embryonated egg and not during its propagation by WSN in the mouse. This is supported by the fact that the only two segment 1 and 2 RNAs found in both the inoculum and the lung were double deleted. All the second deletions in EQV-defective segment 1 RNAs started from nucleotide 2197, whereas most of those found in defective segment 2 RNAs started from nts 58±60. Two additional junction sites were found in segment 2 defective RNAs. There were two different deletions at 2101 to 2111, and another RNA had the nts 61±94 and nts 2138±2050 transposed (Table 3 ). The latter suggests that these two sequence blocks may have been in close proximity in the native conformation, although a   FIG. 4 . Identification of the virus strain from which defective RNAs originated. Defective segment 1 RNAs were isolated from the lungs of mice protected from lethal WSN infection by DI EQV. RNAs isolated from the lungs of mice inoculated with WSN ϩ DI EQV (A) or with WSN ϩ iDI EQV (B) at 4 days p.i. were RT-PCR-amplified using primers complementary to the first 25 nts of EQV, and DNAs obtained cloned into pBluescript. Clones were restricted using PstI and HindIII to excise the defective DNA from pBluescript and then further restricted using NruI (cuts WSN segment 1 at nt 77) and EcoRI (cuts WSN segment 1 at nt 2285). EQV DNA is not cut. A mixture of WSN (W) and EQV (E) DNAs were obtained in (A) but only WSN DNAs in (B). M, marker. The identity of DNAs marked (*) was confirmed by sequence analysis. a Determined by restriction enzyme analysis; the origin of some RNAs (in parenthesis) was confirmed by sequence analysis. iDI, DI virus that had been given prolonged UV-irradiation so that it no longer protected WSN-infected mice. recent study of RNP cores does not support this idea (Klumpp et al., 1997) . Most (45/51) of the EQV-and WSNdefective RNAs from segments 1 to 3 possessed at least the 5Ј terminal 178 nts of virion RNA. The only exceptions were six RNAs from segment 1 that had a short deletion of eight or nine nucleotides at nts 136±144 from the 5Ј end of vRNA. Thus the defective RNAs analysed here show evidence of nonrandom deletions that have not been detected before (Jennings et al., 1983) . The absence of detectable infectivity in the EQV DI inoculum by plaque assay (Յ10 PFU/ml) and the absence of detectable EQV genomic segments 4 and 6 in protected mice (Fig. 3C) indicates that no infectious EQV was present and therefore that the defective EQV RNAs could not have been derived de novo in the mice. Thus the EQV-defective RNAs described above originated from the inoculum and were propagated by WSN in mouse lung. One, some, or all them are therefore likely to have been responsible for protection against infection and disease.
DISCUSSION
This report considers the nature of defective RNAs in the protection of mice from otherwise lethal influenza virus infections. As well as its potential as an antiviral measure, the heterologous protection afforded by DI EQV (H3N8) to mice with an otherwise lethal WSN (H1N1) infection allowed defective RNAs that originated in the DI virus and were stably replicated in the lung to be distinguished from those that accompanied the infectious virus or were generated de novo. Thus the discussion concentrates on heterologous protection.
Possible significance of sequence in the selection of defective RNAs in mouse lung
The marked selection of defective RNAs from segments 1 to 3 in the lungs of mice inoculated with WSN ϩ DI WSN (Results; Noble and Dimmock, 1995) was not seen in mice inoculated with WSN ϩ DI EQV or EQV ϩ DI EQV. In the latter two, defective segment 4 RNAs and sometimes defective segment 5 and 6 RNAs were detected despite, in the case of the WSN ϩ DI EQV group, the absence of detectable replicating EQV. Thus survival of defective EQV segments 4, 5, and 6 is not dependent on the presence of EQV. EQV segment 4 defective RNAs were also seen in mice given WSN ϩ iDI EQV (Table 2 and confirmed by sequencing), even though they were not detected in the iDI inoculum ( Fig. 2A) . EQV segment 4 defective RNAs were thus amplified readily by WSN, whereas WSN-defective segment 4 RNAs were not amplified even when mice were inoculated with WSN plus a 10,000-fold excess of DI WSN ( Fig. 3 ; Noble and Dimmock, 1995). It is possible that a bias was introduced into the amplification of segment 4 by the use of the shorter WSN reverse primer (Table 1) , but this was not a factor in the detection of segment 5.
The above data suggest that there was a positive selection of EQV, but not WSN, segment 4, 5, and 6 defective RNAs and that this result is influenced by the defective RNA population itself, the host (as WSN-defective segments 1±6 are replicated by WSN in chicken embryos) and the infectious virus. This difference is paralleled by different mechanisms of protection, as DI EQV reduces the multiplication of both infectious EQV and WSN in lungs, whereas DI WSN prevents WSNinduced enhancement of the influx of T cells into the lungs (Dimmock et al., 1986; Dimmock, 1989, 1991; McLain et al., 1992; Morgan and Dimmock, 1992; Morgan et al., 1993; Noble and Dimmock, 1994) .
Comparison of defective RNAs isolated from the DI EQV inoculum and from lungs of mice protected from lethal WSN infection by DI EQV
The inoculum is composed of 10,000 haemagglutinating units (HAU)/ml of noninfectious EQV DI or iDI and 1 HAU/ml infectious WSN. As expected, the small amount of defective WSN RNA present in inoculum was not detected by RT-PCR and sequencing. Because no infectious EQV is present, EQV-defective RNAs can only be replicated in the mouse by the infectious WSN, and because the EQV RNAs cannot be generated de novo in the mouse, they must have been selected from the inoculum population. WSN-defective RNAs were detected in mouse lung and may have been amplified from those unavoidably present in the infectious inoculum or generated de novo. They are evidently not relevant to protection as mice given infectious WSN virus alone do not survive.
Sequence analysis of centrally deleted defective RNAs isolated from the DI EQV inoculum and from the lungs of mice inoculated with the same DI EQV showed that a number of otherwise identical defective RNAs had minor changes (nucleotide substitutions, one or two nucleotide deletions) compared with the parent sequence. Because of this, all such defective RNAs were included in our analysis. Jennings et al. (1983) noted similar minor changes in defective RNAs of A/PR/8/34 (H1N1). Overall 29% of DI inoculum RNAs in our study contained such minor changes compared with 52% of RNAs isolated from mouse lungs. RT-PCR is known to generate point mutations, and these occur usually at a constant rate for a particular sequence under the same conditions. In our study, segment 1 defective RNAs differed, with 22% from the inoculum and 67% from the lung showing minor mutations (Table 4 ). The latter are therefore likely to have arisen during replication of defective EQV by infectious WSN in the lung rather than being generated by RT-PCR.
There is a great variety in the number of nucleotides derived from the 5Ј and 3Ј terminal portions of the parental RNA segment that make up the EQV-defective RNAs, especially in segment 2. However, the junction sites are generally further from the 5Ј or 3Ј terminus in the EQV mouse lung defective RNAs than in the EQV inoculum defective RNAs. For example, segment 1 inoculum RNAs ranged from 96 to 225 nts at the 3Ј end compared with 144±225 nts for those isolated from mouse lung (Table 3 and Fig. 5 ). This difference between inoculum and mouse lung defective RNA populations suggests some selection may be occurring in the lung, and this is apparent in the 3Ј and 5Ј ends of defective EQV segment 1 and 2 RNAs. No such difference was apparent with segment 3 defective RNAs isolated from the inoculum, but the number isolated (n ϭ 4) was very low. The greater quantity of RT-PCR products in inoculum EQV DI virus compared with iDI virus (Fig. 2A) , together with the greater percentage of EQV-defective RNAs isolated from the lungs of DI virus-protected mice compared with the group receiving iDI ( Table 2 ), suggest that protection is indeed due to the effects of the defective RNAs.
In comparing individual segments isolated by RT-PCR, some bias in the RT-PCR due to differences in the terminal sequences of EQV and WSN sequences (Table 1) cannot be ruled out. Sensitivity studies show, however, that segment 1, 2, and 3 primers used for sequencing are equivalent at the annealing temperature chosen (data not shown) and are unlikely, therefore, to account for the differences observed.
Sequence analysis of defective RNA isolated from the DI EQV inoculum and from lungs of mice protected from a lethal WSN infection
Generation of deletions and changes in defective EQV
RNAs. Previously, Jennings et al. (1983) analysed 35 PR8-defective RNAs from infected eggs and six other PR8-defective RNAs isolated by others (Moss and Brownlee, 1981; Winter et al., 1981; Fields and Winter, 1982; Nayak et al., 1982; Sivasabramanian and Nayak, 1983) , making a total of 41 RNAs originating from all segments except segment 7, although most (24/41) were derived from segment 1. Here, 51 defective RNAs (47 EQV and 4 WSN), from segments 1 to 3, were isolated from eggs and infected mouse lungs, the majority being from EQV (subtype H3N8) that has not been studied before.
Both studies detected minor sequence changes in defective RNAs, and these may have resulted from drift because of the lower selection pressure on defective RNAs (Winter et al., 1981) . However, the level of 5% reported by Jennings et al. (1983) contrasts with the 22±67% found here. This may be because different viruses were used, the different host, and/or the replication of EQV RNAs by a heterologous virus (WSN).
The data from restriction digests (Fig. 4 and Table 2 ) carried out on EQV-and WSN-defective RNAs extracted from mice inoculated with DI EQV ϩ WSN or iDI EQV ϩ WSN suggest that segment 3 defective EQV RNAs outcompeted their WSN counterparts. Segment 2 defective RNAs competed less well, and segment 1 defective RNAs competed least well, despite all three segments being subject to the same 10,000-fold excess of defective RNA in the protected group. A comparison of segment 3 inoculum and mouse lung defective RNA populations revealed little divergence in terms of minor changes or the proportion of the 5Ј and 3Ј ends of genomic molecule that contribute to making the defective RNA, whereas the two segment 1 populations showed the most differences (Tables 3 and 4 and Fig. 5 ). This suggests that WSN replicates segment 1 defective EQV RNAs less efficiently than segment 3 EQV-defective RNAs. A nonrandom reassortment of virion RNA segments or generation of defective RNAs also suggests that not all influenza segments are equally compatible between different strains (Lubeck et al., 1979; Odagiri and Tobita, 1990; Subbarao et al., 1995) .
Apart from the minor changes, there were also short deletions (4±39 nts) in some defective RNAs. We isolated 15/51 such RNAs from segments 1 and 2, but none from segment 3 (Table 3 ), a higher frequency than found by others (5/41; Jennings et al., 1983) . These changes may take place in eggs after the central deletion has occurred, since we isolated two segment 1 RNAs with an identical central deletion, but only one of which contained a second deletion (of 9 nts: Table 3 ).
All the short deletions in segment 1 defective RNAs have a common 3Ј junction at nucleotide 2197 (vRNA), and most of those deletions in segment 2 defective RNAs have a common 3Ј junction at nts 58±60 (vRNA), but are heterogeneous at the 5Ј junction (Table 3 ). The segment 2 double deletions particularly are suggestive of generation by a detaching and reattaching (jumping) polymerase during positive strand synthesis (proceeding 3Ј to 5Ј) that has a common start point and a heterogeneous 5Ј reattachment point. Others have suggested that defective influenza RNAs are generated during positive strand synthesis (Robertson et al., 1981; Fields and Winter, 1982) .
Two EQV-defective segment 3 RNAs possess a short sequence from the 3Ј end of segment 1 EQV vRNA (nts 168±198, Table 3 ) at the central junction. Differences from the WSN sequence mean that this insert must be EQV in origin. Only one previous description of a defective RNA derived from two different segments exists and this was also segment 3 with a short central insert from the 3Ј end of segment 1 vRNA (Moss and Brownlee, 1981; Fields and Winter, 1982; Jennings et al., 1983) .
Studies of the generation of defective viral RNAs in other (plant) systems (White and Morris, 1995) suggested the presence of sequence identity and complementarity in directing deletions. However, this was not borne out by previous studies on influenza defective RNAs (Jennings et al., 1983) . Although in our study some of the central deletions showed limited sequence identity, others did not and no particular site seemed to be involved. The short deletion site at nt 2197 on segment 1 does, however, show a sequence repeat (2191 -GCTAATGTGCTA-ATT -2205), whereas the segment 2 short deletion site does not (51 -CTTAAAGGTGCCAGCGC -67). The exact site at which the short deletions occurred was sometimes difficult to pinpoint and, if ambiguous, was assigned to the same start point as the longer deletions, all of which were unambiguous.
Minimum 5Ј sequence of defective EQV vRNAs. Despite the lack of a particular site for the central deletions, all but two of our defective RNAs, derived from segments 1±3, possessed at least 178 nts from the 5Ј end (vRNA) (Table 3) , as did two segment 4 and two segment 5 defective RNAs (data not shown). The only two exceptions lacked 8 or 9 nts at nt 2197. The 3Ј site of central deletions was also further from the 3Ј end of the mouse lung RNAs than those isolated from the inoculum (Fig. 5) . Furthermore, a number of segment 1 central deletions arise between nts 200 and 225 from the 5Ј end (vRNA), a number of segment 2 central deletions arise between nts 225 and 250 from the 5Ј end, and a number of segment 3 central deletions arise between nts 275 and 300 from the 5Ј end (Table 3 ). This can be seen as a double peak in Fig. 5 and suggests that these sequences may be required in vivo, possibly for genetic stability. This requirement may be different for each segment. The overall increase in size of mouse lung EQV-defective RNAs compared with those in the inoculum contrasts with a reduction in size of WSN-defective RNA on passage found in cell culture (Janda et al., 1979; De and Nayak, 1980; Sivasabramanian and Nayak, 1983) . However, the latter RNAs were not sequenced, and RNAs that had undergone successive rounds of replication and packaging could not be distinguished from newly synthesised RNAs.
Properties of defective RNAs involved in the protection of mice from lethal influenza virus infection
The defective RNAs analysed above were isolated from the lungs of protected mice and were therefore likely to have been responsible for that protection. Defective RNAs from different segments were not equally represented, e.g., EQV segment 1 defective RNAs were present in protected, but not unprotected mice; and segment 4, 5, and 6 defective RNAs were present in DI EQV-protected but not DI WSN-protected mice, regardless of the infecting virus being WSN or EQV. Future design of protective DI virus preparations will need to examine this question of segment of origin of constituent defective RNAs. The need for a critical amount of defective RNA in the protective inoculum was also indicated in this study, but more information is needed about the relative amount of each type of defective RNA that is required for protection. Defective RNAs isolated from protected mice contained a greater proportion of internal sequences than those isolated from the inoculum and, further, as mentioned above, different segments appeared to possess different proportions of the 5Ј end of vRNA. This has not been observed before, and possession by RNAs of these sequences may enhance their propagation in the mouse and thus their ability to inter-fere with virus replication in the mouse. It would be interesting to know what role, if any, these sequences have in a normal virus infection.
In summary, we have studied the RNAs present in homologous or heterologous DI influenza virus preparations that, when administered intranasally, protect mice from a lethal dose of WSN (H1N1) or EQV (H3N8) influenza virus. Few defective RNAs were isolated from lungs of mice given EQV or EQV ϩ iDI EQV, while defective RNAs from segments 1 to 6 (or on occasion only 1 to 4) were present in lungs of mice given EQV ϩ DI EQV. Thus protection correlated with the presence of defective RNAs. A detailed analysis of defective RNAs isolated from the lungs of mice protected from a lethal WSN infection by DI EQV showed that most were EQV in origin. Thus as no infectious EQV was present, at least some of the defective RNAs from the DI EQV inoculum must have been replicated by WSN in mouse lung. Further it appeared that WSN preferentially replicated defective EQV RNAs from segments 3±6 as the equivalent segments of defective WSN RNA were not isolated. Segment 1 and 2 RNAs were a mixture (53% of segment 1 and 74% of segment 2 were EQV). Of 17 different defective EQV segment 1±3 RNAs isolated from mouse lung, all but 3 differed in sequence (i.e., the primary central deletion) from 20 defective RNAs isolated from the inoculum. Their deletions had no common break point. Some defective EQV and WSN RNAs (13/47) also had minor deletions of two or more nts. All were derived from segments 1 (n ϭ 5) and 2 (n ϭ 8). The minor segment 1 and 2 deletions had common 3Ј breakpoints at nt 2197 and nts 58±60 of vRNA, respectively, and were thought to have arisen in the chicken embryo. Their 5Ј breakpoints were heterogeneous, suggesting that the defective RNAs were generated during positive strand synthesis. Two cloned EQV-defective segment 3 RNAs were chimeras containing a 30-nt insert from segment 1. All defective RNAs possessed at least 178 nts from the 5Ј end of vRNA, although two had an extra deletion of 8 or 9 nts within this region. The actual amount of 5Ј sequence present correlated with segment, suggesting that this is the minimum required for RNA propagation in the chick embryo and adult mouse lung. We are now investigating the ability of defined defective RNAs, alone and in combination, to protect against disease.
MATERIALS AND METHODS
Viruses, DI viruses, and cells
We used A/equine/Newmarket/A/7339/79 (EQV: H3N8) and A/WSN (H1N1). Infectious viruses were adapted to lethality in mice by passage in mice. Stocks were then prepared by inoculation into the allantoic cavity of embryonated eggs at a high dilution to minimize the generation/propagation of DI viruses and were assayed by haemagglutination (HA) of chick red blood cells and by plaque assay in MDCK cells. Whilst infectious WSN preparations also contained defective segment 1, 2, and 3 RNAs, infectious EQV usually contained no detectable defective RNAs (data not shown). DI virus was prepared as described previously (Dimmock et al., 1986) . Briefly, non-mouse-adapted virus was passaged three times at high multiplicity in eggs and then concentrated to 10 4 HAU/ml. DI virus was UV irradiated for 30 s to remove residual infectivity (Dimmock et al., 1986) . Inactivated (non-interfering) DI virus (iDI) was prepared by UVtreatment for 4 min (Noble and Dimmock, 1994) . iDI virus did not lose HA or neuraminidase activity and was used as a control immunogen in mice.
Mice C3H/He-mg (H-2 k ) mice were originally obtained from Bantin and Kingman Ltd., Grimston, Aldborough, Hull, and subsequently bred at Warwick University Animal Facility. All experiments followed the guidelines laid down by the UK Co-ordinating Committee for Cancer Research. Mice were given a lethal dose of 10 LD 50 of WSN or EQV as described previously (Dimmock et al., 1986) . Briefly, 5-week-old mice of either sex were inoculated intranasally under light ether anaesthesia with two intranasal doses given 2 h apart. The first dose (20 l) contained PBS or DI virus (irradiated briefly to remove infectivity) or iDI virus (irradiated for a prolonged period to destroy interfering activity). The second dose (20 l) was PBS or the same DI preparation (10 4 HAU/ml) containing infectious virus (approximately 1 HAU/ml). This regimen was optimised to provide maximum protection of mice (Dimmock et al., 1986) . When required, mice were killed by cervical dislocation, their lungs removed, and RNA extracted immediately. Morbidity was assessed twice daily as a measure of infection. Initially mice developed malaise, ruffled fur, inactivity, and respiratory distress. Progress was signified by altered gait, hunched posture, laterally constricted abdomen, and failure to gain weight. Some also developed ra Ãles but this was not always observed. The percentage morbidity was calculated from the numbers of mice that showed at least the initial combination of clinical signs listed. Each group contained eight mice, two of which were removed for extraction of lung RNA at the time of maximum lung infectivity titer (at 2 days p.i. for EQV-infected mice, and at 5 days p.i. for WSN-infected mice).
RNA extraction
Total cellular RNA was extracted (G. P. Thomas, personal communication) from each pair of mouse lungs by homogenising in a pestle and mortar with sand (Ϫ50 to ϩ70 mesh, Sigma Chemical Co., Poole, Dorset) in the presence of 4 M guanidium thiocyanate in 50 mM Tris.HCl (pH 7.6), 10 mM EDTA (pH 8), 2% N-lauroylsarcosine, and 1% mercaptoethanol. Lysates were extracted in 50 ml polypropylene tubes at 60°C for 10 min with one volume of phenol (pH 4.5), one volume of chloroform, and two volumes of 0.1 M sodium acetate. Tubes were chilled briefly on ice and centrifuged at 3000 rpm for 10 min on a Beckman GPR centrifuge, before being reextracted with phenol (pH 4.5) and chloroform at 60°C for 10 min. Following chilling and centrifugation, RNA was precipitated with two volumes of ethanol at Ϫ20°C. Pellets were treated with 50 g/ml proteinase K in 10 mM Tris (pH 7.8), 5 mM EDTA (pH 8), 0.5% SDS at 37°C for 20 min, then reextracted twice with phenol (pH 4.5) and chloroform at 60°C. Extracted RNA was precipitated with 0.1 M sodium acetate and 2.5 volumes of ethanol. RNA was extracted from DI and inactivated DI virus inoculum by the hot phenol method (Duhaut and McCauley, 1996) .
RT-PCR
Primers complementary to the first 25 nucleotides of the 3Ј end of each segment of EQV influenza were used in first strand DNA synthesis for all WSN and EQV segments, except WSN segments 4 and 6. For these we used primers complementary to their first 20 nucleotides (see Table 1 ), as their sequences differed significantly from EQV. EQV primers were chosen to minimise cross-reactions noted earlier (Noble and Dimmock, 1995) . Primer pairs for WSN-and EQV-defective RNA detected down to 10 4 molecules (10 fg) for segment 1, and 10 5 molecules (100 fg) for segments 2 and 3, the major limiting factor in sensitivity being the RT step. RNA was reverse transcribed in 20 l reaction buffer [50 mM Tris.HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 , 10 mM dithiothreitol (DTT), 1 mM of each dNTP, 10 U ribonuclease inhibitor (Gibco BRL, Paisley), 13 U Moloney murine leukaemia virus reverse transcriptase (Gibco BRL), 200 pmoles complementary primer] at 37°C for 60 min. Second strand DNA synthesis of segments 3 and 8 of both strains (sequence of EQV strain used not available) and 4 and 6 of WSN was primed by UNI2B, which is homologous to the 5Ј terminus of all eight vRNA segments. Segments 1, 2, 5, and 7 of both strains and 4 and 6 of EQV strains were amplified using primers complementary to the first 25 nucleotides of the 5Ј end of each segment of equine influenza (Table 1) . PCR was carried out in 20 mM Tris.HCl (pH 8.4), 50 mM KCl, 2 mM MgCl 2 , 0.2 mM of each dNTP, 2.5 U Taq DNA polymerase (Gibco BRL), 20 pmoles primer, and 20 l first strand synthesis and overlaid with paraffin. Reactions were performed in a PCR block [Techne (Cambridge) Ltd.] for 30 cycles of 60 s at 94°C, 60 s at 55°, and 120 s at 72°C, followed by a final cycle of 72°C for 5 min. The annealing temperature chosen was below the T m of all but the UNI2B and the segment 6 forward primer. PCR products were separated on 2% agarose gels alongside DNA markers (Gibco-BRL).
Cloning and sequencing
RT-PCR products were purified from agarose gel slices by electroelution into 10 mM Tris.HCl (pH 8) and 1 mM EDTA (pH 8). Purified products were blunt-ended by incubation with 4 U DNA polymerase I (large fragment), 50 mM Tris.HCl (pH 8), 7 mM MgCl 2 , 1 mM DTT, and 0.2 mM of each dNTP at 37°C for 30 min. DNA was then cloned into the pBluescript vector (Stratagene) at the EcoR V site. DI clones were separated from vector sequences by digestion with PstI and HindIII and identified by further restriction analysis: for segment 1, NruI (cut WSN at nt 77) and EcoRI (cut WSN at nt 2285); for segment 2, BsmFI (cut WSN at nt 136) and EcoRV (cut WSN at nt 2157); for segment 3, ClaI (cut WSN at nt 185) and BsmFI (cut WSN at nt 2056 and nt 2073); for segment 4, AccI (cut EQV at nt 70) and BglI (cut EQV at nt 1696). Sequencing was performed on a 373a automated DNA sequencer (Perkin-Elmer Applied Biosystems). A total of 5 of 60 clones (8.3%) that comprised linear viral sequences or random fragments and may have been RT-PCR or cloning artifacts were excluded from the analysis.
